The abnormally high expression of PROS1 played critical roles in the promotion of the growth of glioblastoma,[15] oral squamous cell carcinoma,[16] and colorectal cancer.[17] However, in this study, we found low expression of PROS1 mRNA was significantly associated with poor OS in PTC patients. The gene discussed is PROS1; the disease is oral cavity squamous cell carcinoma.